logo

For the Inventor, By the Inventor

Belleville, Canada

Bioniche Life Sciences Inc.


USPTO Granted Patents = 18

% Expired Patents = 77.8


Trademarks = 8

Forward Citations = 109

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Nigel C Phillips (14 out of 19 patents)

silverMedal Mario C Filion (14 out of 18 patents)

bronzeMedal Stéphanie Reader (4 out of 5 patents)

4.  Zdenek Richard Holan (3 out of 7 patents)

5.  John Douglas Baker (2 out of 3 patents)

6.  John Thor Arnason (2 out of 8 patents)

7.  Stanley J Alkemade (2 out of 10 patents)

8.  Calum McRae (2 out of 2 patents)

9.  Jose M Wade (2 out of 2 patents)

10.  Phillippe Riviere (1 out of 1 patent)

11.  Marc Riviere (1 out of 1 patent)

12.  Andrea C Herréra Gayol (1 out of 1 patent)

13.  Bruce J Nosky (1 out of 1 patent)

14.  Robert E Pitts (1 out of 1 patent)

15.  Dragan R Rogan (1 out of 2 patents)


18 patents:

1. 8350016 - Oligonucleotide compositions and their use to induce apoptosis (2013-01-08),
2. 8293745 - Use of imatinib to treat liver disorders and viral infections (2012-10-23),
3. 7985432 - Insect repellent (2011-07-26),
4. 7893242 - Oligonucleotide compositions and their use to induce apoptosis (2011-02-22),
5. 7662792 - Modulation of Fas and FasL expression (2010-02-16),
6. 7635686 - Therapeutically useful triethyleneglycol cholesteryl oligonucleotides (2009-12-22),
7. 7381431 - Insect repellent (2008-06-03),
8. 7371734 - Oligonucleotide compositions and their use for the modulation of immune responses (2008-05-13),
9. 7199228 - Oligonucleotide compositions and their use to induce apoptosis (2007-04-03),
10. 7157436 - Therapeutically useful synthetic oligonucleotides (2007-01-02),
11. 7125858 - Hyaluronic acid in the treatment of cancer (2006-10-24),
12. 7087586 - Oligonucleotide compositions and their use to induce differentiation of cells (2006-08-08),
13. 6890911 - Method for the treatment of inflammation (2005-05-10),
14. 6890541 - Method for enhancing production performance in an animal (2005-05-10),
15. 6809081 - Chemotherapeutic composition and method (2004-10-26),
Company Overview
Bioniche Life Sciences Inc. is a biotechnology company based in Belleville, Canada, focused on developing innovative solutions for animal health and human health. The organization specializes in the research, manufacturing, and commercialization of therapeutic products, particularly in the fields of immunology and oncology. Bioniche is dedicated to advancing healthcare through its proprietary technologies and aims to address unmet medical needs in both veterinary and human medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

18 Patents

#1 in Belleville

#821 in Canada

#34,187 in the World

Belleville, CA
Belleville, Canada

Bioniche Life Sciences Inc.

Forward Citations = 109

15 inventors:

goldMedal Nigel C Phillips (14 out of 19 patents)

silverMedal Mario C Filion (14 out of 18 patents)

bronzeMedal Stéphanie Reader (4 out of 5 patents)

4.  Zdenek Richard Holan (3 out of 7 patents)

5.  John Douglas Baker (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioniche Life Sciences Inc.. Retrieved from https://idiyas.com/company/bioniche-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…